Rare diseases
Investigational molecules
Locations
A study testing how well cagrilintide and semaglutide help people with overweight or obesity lose weight
FranceA study testing cagrilintide and semaglutide compared to placebo in people with type 2 diabetes taking basal insulin with or without metformin
SlovakiaStudy comparing semaglutide and dapagliflozin taken separately or combined in one tablet for type 2 diabetes patients
GermanyStudy of cagrilintide and semaglutide combination versus placebo in people with type 2 diabetes and painful diabetic peripheral neuropathy
DenmarkStudy comparing RO7795081 and semaglutide with placebo in adults with type 2 diabetes mellitus
HungaryStudy on the Effects of Ertugliflozin and Semaglutide on Heart Health in Patients with Type 2 Diabetes
ItalyStudy of Semaglutide and Glucagon Effects on Energy Expenditure and Glucose Levels in Healthy Volunteers
LatviaStudy on Semaglutide for Young Adults with Early-Onset Obesity Resistant to Lifestyle Changes
DenmarkStudy on Personalized Treatment Using Dapagliflozin, Dulaglutide, and Metformin for Patients with Uncontrolled Type 2 Diabetes
SpainStudy on Maintaining Weight Loss in Teens with Obesity Using Semaglutide
BelgiumStudy on the Long-term Weight Loss Effects of Cagrilintide and Semaglutide in Adults with Obesity
BelgiumStudy on Semaglutide for Patients with Obesity and Resistant Hypertension to Improve Blood Pressure Control
IrelandTell us about your condition – we search every trial in Europe and connect you with the right site.
